Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

NCT03404856 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Glycogen Storage Disease, Type 14

Interventions

DRUG: ORL-1G - D-galactose

Sponsor

Orpha Labs